Skip to main content

Table 2 Number of samples with active pharmaceutical ingredient found different to what the medicine was labelled as containing

From: Mind the gaps - the epidemiology of poor-quality anti-malarials in the malarious world - analysis of the WorldWide Antimalarial Resistance Network database

Active pharmaceutical ingredient found in anti-malarial medicine samples

Medicine labeled as

References

AS

CQ

DHA

HL

MQ

QN

TET

AL

SMP + PYR

DHA + PQP

2-Mercaptobenzothiazole

3

         

[38]

Acetaminophen

17

 

1

7

    

101*

 

[5, 38, 40–42]

Artemisinin

4

  

4

      

[5, 38]

Aspirin

 

1

        

[43]

Chloramphenicol

2

         

[38]

Chloroquine

8

    

253*

    

[5, 34, 38, 41, 44–46]

Chlorpheniramine

 

1

        

[47]

Dimethylfumarate

6

         

[38]

Erucamide

1

         

[38]

Erythromycin

7

         

[38, 48]

Erythromycin and Paracetamol (acetaminophen)

8

         

[49]

Sulphadoxine-pyrimethamine

        

100*

 

[50]

Metamizol

5

         

[38]

Pyrimethamine

8

      

2

  

[5, 38]

Pyrimethamine and Sulphadiazine

       

1

  

[5]

Sildenafil

         

4

[5]

Soya flour

      

100*

   

[50]

Sulphadoxine

12

  

57600

      

[38, 39]

Sulphadoxine-pyrimethamine

30

   

1

     

[51, 52]

Sulphamethazine

   

1

      

[53]

  1. 100* = Unknown number of samples. Missing number of samples from one set of samples of chloroquine, mefloquine, sulphadoxine-pyrimethamine and three set of samples of quinine. Anti-malarial medicines: AS: artesunate, CQ: chloroquine; DHA: dihydroartemisinin; HL: halofantrine; MQ: mefloquine; QN: quinine; TET: tetracycline; AL: artemether-lumefantrine; SMP + PYR: sulphamethoxypyrazine-pyrimethamine; DHA + PQP: dihydroartemisinin-piperaquine.